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Preparation of Organometallic Complexed Sugars:  




Paul J. Kleindl  
Department of Chemistry, Marquette University, P.O. Box 1881, Milwaukee, Wisconsin 
William A. Donaldson 




There has been considerable recent interest in the preparation of biologically important molecules 
which are “tagged” with a metal carbonyl group. Such compounds have been examined for use in 
carbonyl metallo immunoassays (CMIA) using FT-IR spectroscopy.1 While the majority of these 
“tagged” molecules are within the steroidal family, the preparation of organometallic nucleotides,2 
leukotrienes,3 and carbohydrates4 have also been reported. σ-Bonded manganese and iron carbonyl 
complexes of carbohydrates have been prepared by displacement of 1-glucosyl halides or 6-deoxy-6-
haloglucosides. Due to the lability of the metal−carbon σ bond, the majority of these metallo-sugar 
complexes are reported to be unstable. As part of our broader interest in developing methodology for 
the application of (TMM)Fe(CO)3 complexes [(TMM) = trimethylenemethane] in organic synthesis,5 we 
have investigated the hetero Diels−Alder reaction6 of tricarbonyl(formyl-TMM)iron (1)7 and further 
elaboration into 4,6-dideoxypyranoside derivatives.  
The reaction of racemic 1 with 1-methoxy-3-[(trimethylsilyl)oxy]-1,3-butadiene (2), in the presence of 
BF3·Et2O, followed by treatment with trifluoroacetic acid gave the dihydropyrone complex 3 as a single 
diastereomer (52%, eq 1).8 Since cyclocondensation of 1 with 2 in the presence of BF3·Et2O occurred in 
a diastereospecific fashion, the use of other Lewis acid catalysts was not attempted. The relative 
stereochemistry of 3 was assigned as indicated on the basis of single crystal X-ray diffraction analysis.9 
Dihydropyrone 3 arises via attack of 2, in the s-trans conformer, on the face of the aldehyde which is 
opposite to the sterically bulky Fe(CO)3 group. This present diastereoselectivity is consistent with that 
observed for addition of nucleophiles to 1.7,10 This high selectivity for this cyclocondensation (>25:1) is 
superior to that observed for the cyclocondensation of (dienal)Fe(CO)3 complexes (4) with 2 (<4:1).11 
The aldehyde complexes 1 and 4 may each exist in an equilibrium between their two conformers, s-
trans and s-cis (Figure 1). In the case of 1, the s-trans conformer is more stable than the s-cis 
conformer due to the severe steric interactions between the carbonyl oxygen and the neighboring 
methylene group, while for 4 the s-trans and s-cis conformers are closer in energy.12 
 
Figure 1 
Reaction of 3 with mercuric acetate in methanol, followed by treatment with NaBH3CN gave the 
methoxy ketone 5 (74%, Scheme 1). Compound 5 was assigned the β-stereochemistry on the basis of 
1H NMR signal for the anomeric proton (δ 4.49, dd, J = 2.8, 8.9 Hz). Reduction of 5 with LiAlH(OtBu)3 
gave alcohol 6 (78%, Scheme 1). Reduction of β-pyranoside ketones under these conditions is expected 
to afford predominantly the equatorial alcohol.13 The product was assigned the stereochemistry as 
shown on the basis of its 1H NMR spectral data. In particular, the signals for the H1 (δ 4.21, dd, J = 1.8, 
9.6 Hz) and for H3 (δ 3.83, br m, HW = 26 Hz) are consistent with a tetrahydropyran bearing all 
equatorial substituents. 
Scheme 1 
Reduction of 3 gave the pseudo glycal 7 (86%) which was protected as the TBS ether 8 (86%, Scheme 
2). Osmylation of 8, followed by acylation gave the 4,6-dideoxy-glucopyranose TMM complex 9 as a 
separable mixture of α- and β-anomers (2:1, 80%, Scheme 2).14 The stereochemistry of the products 
was assigned on the basis of their 1H NMR spectral data. In particular, the signals for H2ax and H3ax of 9-
α appear at δ 4.80 (dd, J1-2ax = 3.7, J2ax-3ax = 9.5 Hz) and 4.03 (dt, J3ax-4eq = 4.5, J3ax-4ax = 9.4 Hz), 
respectively, while for 9-β the signal for H2ax appears at δ 4.83 (t, J1-2ax = J2ax-3ax = 8.8 Hz). Ferrier 
rearrangement15 of 7 (iPrOH/pTsOH) gave the unsaturated acetal 10 as a mixture of anomers (4.5:1, 
89%, Scheme 2) from which the α-anomer could be cleanly separated by chromatography. Osmylation 
of 10, followed by in acylation gave the 4,6-dideoxy-mannopyranose TMM complex 11 (81%, Scheme 
2). The stereochemical assignment for 11 was based on its 1H NMR spectral data. 
Scheme 2 
All of the (TMM)Fe(CO)3 complexes 3, 5−11 exhibit five signals in their 1H NMR spectra at ca. δ 2.9 (dd, 
J = 2.2, 9−10 Hz), 2.6−2.45 (d, J = ca. 4.4 Hz), 2.15 (d, J = 2.2 Hz), 1.9−1.8 (s), and 1.8−1.7 (d, J = 4.4 Hz) 
corresponding to the TMM protons. The carbohydrate derivatives 6, 9, and 11 all exhibit characteristic 
metal carbonyl stretching frequencies of ca. 2060 and 1990 cm-1 which could be useful for CMIA. Since 
the precursor 1 can be obtained in optically active form via classical resolution10,16 or by enzyme-
mediated kinetic resolution,17 it should be possible to obtain these carbohydrate−TMM complexes in 
optically active form. Furthermore, since stability of the metal carbonyl complexes under biological 
conditions is important for CMIA, it should noted that (TMM)Fe(CO)3 complexes appear to be more 
robust than the corresponding (diene)Fe(CO)3 counterparts under a variety of reaction conditions 
including oxidations.18 
Experimental Section 
General Data. Unless otherwise noted, reactions were carried out in flame-dried glassware under an 
atmosphere of nitrogen. Spectrograde solvents were used without purification with the exception of 
tetrahydrofuran and diethyl ether which were distilled from the potassium and sodium benzophenone 
ketyls, respectively; methanol which was distilled from magnesium turnings; and CH2Cl2 which was 
distilled from P2O5. 1-Methoxy-3-[(trimethylsilyl)oxy]-1,3-butadiene (90%) was purchased from Aldrich 
Chemical Co. and used without further purification. Column chromatography was performed on silica 
gel grade 62, 60−200 mesh, 150 Å (Aldrich). Elemental analyses were obtained from Midwest 
Microlabs, LTD, Indianapolis, and high resolution mass spectral determinations were made at the 
Washington University Resource for Biomedical and Bio-organic Mass Spectrometry. Melting points 
were determined for samples in open capillaries and are uncorrected, and 1H and 13C NMR spectra 
were recorded in CDCl3 solution at 300 MHz and 75 MHz, respectively.  
Cyclocondensation of 1. To a solution of aldehyde 17 (3.34 g, 15.0 mmol) and 1-methoxy-3-
[(trimethylsilyl)oxy]-1,3-butadiene (2) (3.23 mL, 15.0 mmol) in ether (25 mL) at −78 °C was added 
dropwise over a period of 10 min BF3·Et2O (1.9 mL, 15 mmol). The mixture was stirred for 3.5 h, and 
then saturated aqueous NaHCO3 was added. The mixture was allowed to warm to rt and separated, 
and the aqueous layer was extracted with ether. The combined organic layers were washed with brine 
and dried (MgSO4), and the solvent was evaporated to afford a reddish brown crystalline mass. This 
residue was dissolved in CCl4 (25 mL), trifluoroacetic acid (7 drops) was added, and the mixture was 
stirred for 5 h at rt. Saturated aqueous NaHCO3 was added, the layers were separated, and the 
aqueous layer was extracted with ether. The combined organic layers were washed with brine and 
dried (MgSO4), and the solvent was evaporated. The residue was purified by chromatography (SiO2, 
hexanes−ethyl acetate (10:1 to 2:1 gradient)) to give 3 as a yellow solid (2.24 g, 52%). 3:  mp 
107−110 °C; IR (CHCl3, cm-1) 2052, 2012, 1690, 1618; 1H NMR (CDCl3) δ 7.35 (dd, J = 0.6, 6.0 Hz, 1H), 
5.42 (dd, J = 1.1, 6.0 Hz, 1H), 3.91 (ddd, J = 3.7, 10.0, 13.7 Hz, 1H), 2.92 (dd, J = 2.4, 10.0 Hz, 1H), 2.78 
(dd, J = 13.4, 16.6 Hz, 1H), 2.58 (ddd, J = 1.2, 3.4, 16.6 Hz, 1H), 2.46 (dd, J = 1.0, 4.2 Hz, 1H), 2.21 (dd, J = 
1.5, 1.9 Hz, 1H), 1.92 (s, 1H), 1.84 (d, J = 4.4 Hz, 1H); 13C NMR (CDCl3) δ 211.8, 211.3, 191.4, 163.3, 
107.2, 103.8, 77.9, 74.7, 52.3, 51.8, 45.5. Anal. Calcd for C12H10O5Fe:  C, 49.69; H, 3.47. Found:  C, 49.49; 
H, 3.48.  
β-Methyl Glucoside 5. To a solution of dihydropyrone 3 (188 mg, 0.649 mmol) in dry methanol (7 mL) 
was added Hg(OAc)2 (226 mg, 0.798 mmol). The reaction mixture was stirred at rt for 24 h, diluted with 
methanol (2 mL), and cooled to −78 °C. To the cooled solution was added a solution of NaBH3CN (18.9 
mg, 0.301 mmol) in methanol (2 mL). The reaction mixture was stirred for 2.5 h, diluted with ethyl 
acetate, and filtered, and the solvent was evaporated. The residue was purified by chromatography 
(SiO2, hexanes−ethyl acetate (20:1 to 2:1 gradient)) to give 5 as a yellow syrup which solidified in the 
refrigerator (155 mg, 74%). 5:  mp ≈ 35 °C; IR (CHCl3, cm-1) 2062, 1996, 1724, 1130; 1H NMR (CDCl3) δ 
4.49 (dd, J = 2.8, 8.9 Hz, 1H), 3.54 (s, 3H), 3.15 (dt, J = 3.6, 10.0 Hz, 1H), 2.93 (dd, J = 2.3, 9.4 Hz, 1H), 
2.63 (ddd, J = 1.6, 2.8, 14.9 Hz, 1H), 2.58−2.35 (m, 4H), 2.18 (dd, J = 1.1, 2.3 Hz, 1H), 1.88 (s, 1H), 1.81 
(d, J = 4.4 Hz, 1H); 13C NMR (CDCl3) δ 211.2, 211.0, 210.9, 204.6, 103.3, 101.6, 78.2, 70.9, 57.3, 53.1, 
52.3, 50.9, 48.0. Anal. Calcd for C13H14O6Fe:  C, 48.48; H, 4.38. Found:  C, 49.28; H, 4.68.  
Reduction of β-Methyl Glucoside 5. To a solution of 5 (89 mg, 0.28 mmol) in dry THF (20 mL) was 
added dropwise via syringe a solution of LiAlH(OtBu)3 (83 mg, 0.33 mmol) in dry THF (10 mL). The 
reaction mixture was stirred at rt for 1.5 h, at which time TLC analysis indicated completion. Water (10 
mL) was added dropwise, the mixture was extracted with ether, the combined extracts were washed 
with brine and dried (MgSO4), and the solvent was evaporated. The residue was purified by 
chromatography (SiO2, hexanes−ethyl acetate (5:1 to 4:1 gradient)) to give 6 as a yellow oil which 
solidified in the refrigerator (71 mg, 78%). 6:  mp 55−59 °C; IR (CHCl3, cm-1) 3435, 2060, 1989; 1H NMR 
(CDCl3) δ 4.21 (dd, J = 1.8, 9.6 Hz, 1H), 3.83 (br m, HW = 26 Hz, 1H), 3.49 (s, 3H), 2.98 (dd, J = 1.5, 9.3 
Hz, 1H), 2.92 (br q, J = 10.7 Hz, 1H), 2.42 (d, J = 4.6 Hz, 1H), 2.17 (m and s, 2H), 2.06 (br d, J = 12 Hz, 1H), 
1.83 (s, 1H), 1.76 (d, J = 4.4 Hz, 1H), 1.5−1.2 (m, 3H); 13C NMR (CDCl3) δ 210.9, 210.8, 210.6, 102.7, 
101.0, 79.0, 70.7, 66.6, 56.7, 52.4, 51.5, 44.4, 40.4; EI-HRMS m/z 208.0183 (calcd for C9H12O2Fe (M - 
3CO and MeOH) m/z 208.0187).  
Reduction of Dihydropyrone 3. To a solution of dihydropyrone 3 (0.71 g, 2.4 mmol) in C6H6 (35 mL) at 
0 °C was added dropwise via syringe a solution of DIBAL (1.0 M in toluene, 4.9 mL, 4.9 mmol). The 
reaction mixture was stirred at rt for 40 min, diluted with MeOH (5 mL), and poured into saturated 
aqueous Na2SO4. The precipitate which formed was removed by filtration and the solid washed with 
ethyl acetate. The filtrate was extracted with ethyl acetate, the combined extracts were dried (MgSO4), 
and the solvent was evaporated. The residue was purified by chromatography (SiO2, hexanes−ethyl 
acetate (10:1 to 1:1 gradient)) to give 7 as a yellow oil (0.616 g, 86%). 7:  IR (CHCl3, cm-1) 3433, 2050, 
1998; 1H NMR (CDCl3) δ 6.36 (br d, J = 5.8 Hz, 1H), 4.74 (dt, J = 6.1, 2.0 Hz, 1H), 4.45 (br t, 1H), 3.50 (s 
and m, 2H), 2.95 (dd, J = 2.4, 10.0 Hz, 1H), 2.46 (d, J = 4.4 Hz, 1H), 2.32 (br dd, J = 6.6, 13.3 Hz, 1H), 2.15 
(dd, J = 1.0, 2.4 Hz, 1H), 1.9−1.8 (m, 1H), 1.83 (s, 1H), 1.75 (d, J = 4.4 Hz, 1H); 13C NMR (CDCl3) δ 210.9, 
210.8, 209.9, 145.1, 105.2, 103.2, 78.1, 73.1, 62.5, 52.2, 51.2, 41.8; EI-HRMS m/z 264.0092 (calcd for 
C11H12O4Fe (M − CO) m/z 264.0085).  
tert-Butyldimethylsilyl Ether 8. To a solution of 7 (0.161 g, 0.551 mmol) in CH2Cl2 (10 mL) were added 
NEt3 (0.6 mL, 4 mmol), tert-butyldimethylsilyl chloride (0.129 g, 0.829 mmol), and DMAP (6 mg). The 
reaction mixture was stirred for 11 h, and additional tert-butyldimethylsilyl chloride (0.134 g, 0.887 
mmol) was added. The reaction mixture was stirred for an additional 25 h and then treated with 
saturated aqueous NaHCO3. The layers were separated, and the aqueous layer was extracted with 
ether. The combined organic layers were dried (MgSO4) and concentrated. The residue was purified by 
chromatography (SiO2, hexanes−ethyl acetate (10:1 to 2:1 gradient)) to give 8 as a yellow oil (0.192 g, 
86%). 8:  IR (CHCl3, cm-1) 2054, 2000, 1641, 1119, 1074; 1H NMR (CDCl3) δ 6.30 (dd, J = 0.9, 6.3 Hz, 1H), 
4.65 (td, J = 1.9, 6.3 Hz, 1H), 4.44 (m, 1H), 3.49 (dt, J = 2.4, 10.0 Hz, 1H), 3.02 (dd, J = 2.3, 9.9 Hz, 1H), 
2.45 (d, J = 4.2 Hz, 1H), 2.17−2.11 (m, 2H), 1.92 (ddd, J = 8.5, 10.7, 13.8 Hz, 1H), 1.81 (s, 1H), 1.73 (d, J = 
4.4 Hz, 1H), 0.90 (s, 9H), 0.08 (s, 6H); 13C NMR (CDCl3) δ 211.1, 210.9, 210.0, 144.4, 105.8, 103.1, 78.7, 
72.9, 63.0, 52.1, 51.2, 41.9, 31.6, 25.8, 22.6, 18.1, −4.6.  
1,2-Di-O-acetyl-3-O-(tert-butyldimethylsilyl)-4,6-dideoxy-6-TMM-glucopyranose (9). To a solution of 8 
(0.50 g, 0.123 mmol) in acetone (10 mL) was added Et4NOAc (0.011 g, 0.042 mmol). After 30 min, the 
solution was cooled to 0 °C, and a solution of OsO4 (1 mL, 0.196 M, 0.196 mmol) in pyridine was added 
dropwise over a 5 min period, followed by tBuOOH (0.03 mL, 0.30 mmol). After 3 h, the reaction 
mixture was quenched with saturated aqueous NaHSO3 (7 mL), warmed to rt, and stirred for 3 h. The 
mixture was diluted with ethyl acetate and filtered through a filter aid. The filtrate was washed with 1 
N HCl, saturated aqueous NaHCO3, and brine, dried (MgSO4), and concentrated. The residue was 
dissolved in CH2Cl2 (10 mL), and pyridine (1.2 mL), acetic anhydride (1.4 mL), and DMAP (6 mg) were 
added. The reaction mixture was stirred for 47 h, diluted with water, and extracted with ether. The 
ether extracts were washed with 1 N HCl and saturated aqueous NaHCO3, dried (MgSO4), and 
concentrated. The residue was purified by chromatography (SiO2, hexanes−ethyl acetate (10:1)) to give 
α-9 as a pale yellow solid (35 mg, 54%) followed by β-9 as a pale yellow solid (17 mg, 26%).  
α-9:  mp 122−127 °C; IR (cm-1):  2063, 1994, 1736, 1250; 1H NMR (CDCl3) δ 6.30 (d, J = 3.7 Hz, 1H), 4.80 
(dd, J = 3.7, 9.5 Hz, 1H), 4.03 (dt, J = 4.5, 9.4 Hz, 1H), 3.45 (m, 1H), 2.78 (dd, J = 2.6, 9.6 Hz, 1H), 2.41 (d, 
J = 4.5 Hz, 1H), 2.15 (br s, 1H), 2.10 (m, 1H), 2.05 (s, 6H), 1.90 (m, 1H), 1.81 (s, 1H), 1.73 (d, J = 4.5 Hz, 
1H), 0.86 (s, 9H), 0.10 (s, 3H), 0.06 (s, 3H); 13C NMR (CDCl3) δ 210.2, 103.1, 90.1, 73.4, 69.0, 65.7, 52.2, 
51.2, 43.8, 25.5, 20.7, −4.5, −4.8.  
β-9:  mp 127−128 °C; IR (CDCl3) 2063, 1996, 1749, 1242, 1055 cm-1; 1H NMR (CDCl3) δ 5.51 (d, J = 8.3 Hz, 
1H), 4.83 (t, J = 8.8 Hz, 1H), 3.82 (m, 2H), 3.20 (t, J = 8.7 Hz, 1H), 2.81 (dd, J = 2.2, 9.0 Hz, 1H), 2.45 (d, J 
= 3.4 Hz, 1H), 2.35 (m, 1H), 2.03 (m and s, 7H), 1.80 (s, 1H), 1.72 (d, J = 4.5 Hz, 1H), 0.86 (s, 9H), 0.08 (s, 
3H), 0.04 (s, 3H); 13C NMR (CDCl3) δ 209.5, 169.5, 169.1, 103.3, 92.0, 74.2, 71.2, 69.9, 53.4, 50.9, 43.6, 
31.6, 25.5, 22.7, 20.9, 17.8, 14.1; EI-HRMS m/z 440.1312 (calcd for C22H32O4SiFe (M − 3CO) m/z 
440.1318).  
Ferrier Rearrangement of 7. To a solution of 7 (276 mg, 0.945 mmol) in isopropyl alcohol (20 mL) at 
23 °C under N2 was added p-toluenesulfonic acid (14 mg). The reaction mixture was stirred for 24 h, 
poured into saturated aqueous NaHCO3, and extracted with ether. The combined organic layers were 
dried (MgSO4), and the solvent was evaporated to give a yellow oil (281 mg, 89%) which was 
determined by 1H NMR spectroscopy to be a mixture of anomers, α-10 and β-10 (4.5:1 ratio). 
Separation by column chromatography gave pure α-10 followed by a mixture of α-10 and β-10 (1:1).  
α-10:  IR (CHCl3, cm-1) 2052, 1988; 1H NMR (CDCl3) δ 5.94 (complex m, 1H), 5.64 (ddt, J = 1.5, 10.2, 4.1 
Hz, 1H), 5.08 (br s, 1H), 4.03 (sept, J = 6.1 Hz, 1H), 3.81 (ddd, J = 4.2, 8.0, 10.0 Hz, 1H), 2.87 (dd, J = 2.7, 
7.8 Hz, 1H), 2.58 (d, J = 4.4 Hz, 1H), 2.15 (m, 3H), 1.77 (s, 1H), 1.70 (d, J = 4.4 Hz, 1H), 1.17 (d, J = 5.6 Hz, 
3H), 1.15 (d, J = 5.6 Hz, 3H); 13C NMR (CDCl3) δ 211.3, 211.2, 210.3, 127.5, 126.1, 102.4, 91.6, 80.7, 68.8, 
65.8, 53.2, 51.0, 34.6, 23.3, 21.2; EI-HRMS m/z 306.0540 (calcd for C14H18O4Fe (M − CO) m/z 306.0554).  
β-10  1H NMR (CDCl3, partial) δ 5.12 (br s), 3.24 (dt, J = 3.4, 9.8 Hz, 1H), 3.02 (dd, J = 2.4, 9.8 Hz, 1H), 
2.44 (d, J = 4.4 Hz, 1H), 1.81 (s, 1H), 1.74 (d, J = 4.4 Hz, 1H).  
Isopropyl 2,3-Di-O-acetyl-4,6-dideoxy-6-TMM-mannopyranoside (11). To a solution of α-10 (0.50 g, 
0.150 mmol) in acetone was added Et4NOAc (0.013 g, 0.050 mmol). After 30 min, the solution was 
cooled to 0 °C, and a solution of OsO4 (1 mL, 0.196 M, 0.196 mmol) in pyridine was added dropwise 
over a 5 min period, followed by tBuOOH (0.03 mL, 0.30 mmol). After 3 h, the reaction mixture was 
quenched with saturated aqueous NaHSO3 (7 mL), warmed to rt, and stirred overnight. The mixture 
was diluted with ethyl acetate and filtered through a filter aid. The filtrate was washed with brine, 
followed by 10% aqueous HCl, and finally saturated aqueous NaHCO3, dried, and concentrated. The 
residue was dissolved in CH2Cl2 (10 mL), and pyridine (1.2 mL), acetic anhydride (1.4 mL), and DMAP (6 
mg) were added. The reaction mixture was stirred for 20 h, diluted with water, and extracted with 
ether. The ether extracts were washed with 1 N HCl (2 × 5 mL) and saturated aqueous NaHCO3, dried, 
and concentrated to give 11 as a yellow solid (0.055 g, 81%). 11:  mp 94−96 °C; IR (CHCl3, cm-1) 2058, 
1994, 1726, 1371; 1H NMR (CDCl3) δ 5.24 (ddd, J = 3.2, 6.0, 11.0 Hz, 1H), 4.89 (t, J = 2.3 Hz, 1H), 4.85 (d, 
J = 1.7 Hz, 1H), 3.87 (hept, J = 6.1 Hz, 1H), 3.69 (dt, J = 5.9, 8.5 Hz, 1H), 2.84 (dd, 2.4, 8.5 Hz, 1H), 2.55 
(d, J = 4.2 Hz, 1H), 2.11 and 2.00 (2 x s, 6H), 1.97−1.89 (m, 3H), 1.78 (s, 1H), 1.69 (d, J = 4.4 Hz, 1H), 1.07 
(d, J = 6.1 Hz, 6H); 13C NMR (CDCl3) δ 212.6, 212.5, 211.9, 171.7, 171.4, 103.4, 96.3, 80.0, 69.8, 69.0, 
67.4, 66.8, 53.4, 51.7, 36.1, 29.9, 23.2, 21.2, 21.1; EI-HRMS m/z 368.0913 (calcd for C16H24O6Fe (M − 
3CO) m/z 368.0922).  
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